IN8bio Inc (INAB)
1.00
-0.02
(-1.96%)
USD |
NASDAQ |
May 03, 16:00
1.00
0.00 (0.00%)
After-Hours: 20:00
IN8bio Total Liabilities (Quarterly): 8.772M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.772M |
| September 30, 2023 | 8.45M |
| June 30, 2023 | 7.919M |
| March 31, 2023 | 7.89M |
| December 31, 2022 | 10.31M |
| September 30, 2022 | 8.819M |
| June 30, 2022 | 4.42M |
| March 31, 2022 | 3.703M |
| Date | Value |
|---|---|
| December 31, 2021 | 4.04M |
| September 30, 2021 | 4.096M |
| June 30, 2021 | 3.903M |
| March 31, 2021 | 4.104M |
| December 31, 2020 | 2.589M |
| June 30, 2020 | 2.812M |
| December 31, 2019 | 1.476M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.476M
Minimum
Dec 2019
10.31M
Maximum
Dec 2022
5.553M
Average
4.104M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Jaguar Health Inc | 45.87M |
| Aptevo Therapeutics Inc | 12.62M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.71M |
| Shareholders Equity (Quarterly) | 24.94M |